Jove
Visualize
Contact Us

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tobacco withdrawal system recovery time assessed during smoking satiety predicts smoking behavior change among individuals who smoke cigarettes daily.

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors·2026
Same author

Behavioral and transcriptomic markers of susceptibility to escalate fentanyl intake.

Translational psychiatry·2026
Same author

Text-Message Outreach to Connect Adolescents and Young Adults to Nicotine Treatment: A Pilot Study in Pediatric Primary Care.

Academic pediatrics·2026
Same author

Microglia ablation is sufficient to prevent spontaneous withdrawal following perinatal morphine exposure.

Brain, behavior, and immunity·2026
Same author

Prefrontal TDCS does not improve working memory performance in individuals with chronic alcohol and tobacco use.

IBRO neuroscience reports·2026
Same author

A HISTORY OF ADOLESCENT OXYCODONE SELF-ADMINISTRATION: NEURAL MECHANISMS UNDERLYING NEUROCOGNITIVE IMPAIRMENTS.

bioRxiv : the preprint server for biology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Translational research in nicotine dependence.

Jill R Turner1, Allison Gold, Robert Schnoll

  • 1Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cold Spring Harbor Perspectives in Medicine
|January 22, 2013
PubMed
Summary

Nicotine addiction causes millions of deaths annually. This review explores using existing medications to target the cholinergic system for new nicotine addiction treatments.

More Related Videos

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Related Experiment Videos

Last Updated: May 15, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Medicine

Background:

  • Nicotine addiction is a major global health issue, causing millions of deaths yearly.
  • Current FDA-approved treatments for nicotine addiction are limited, creating a significant unmet medical need.
  • Developing novel pharmacotherapies is hindered by the complexity of addiction and high drug development costs.

Purpose of the Study:

  • To review translational studies investigating the cholinergic system as a therapeutic target for nicotine addiction.
  • To explore the potential of repurposing existing medications for smoking cessation.
  • To identify promising strategies for developing new nicotine addiction treatments.

Main Methods:

  • Review of preclinical (mouse) and clinical (human) studies.
  • Analysis of translational research focusing on the cholinergic system.
  • Examination of existing FDA-approved medications for potential repurposing.

Main Results:

  • The cholinergic system presents a viable target for nicotine addiction pharmacotherapies.
  • Translational studies suggest that manipulating cholinergic pathways can impact nicotine use.
  • Existing medications may offer a faster and more cost-effective route to new treatments.

Conclusions:

  • Targeting the cholinergic system offers a promising avenue for novel nicotine addiction therapies.
  • Repurposing approved medications could accelerate the development of effective smoking cessation treatments.
  • Further translational research is crucial to validate and optimize these therapeutic strategies.